Early research (Phase 1)Study completedNCT01277692
What this trial is testing
A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.
Who this might be right for
Hepatitis C
GlaxoSmithKline 58